Diabetes Obes Metab 14:514 Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, The PROactive Investigators (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone clinical trial in macro vascular events): a randomised controlled trial
avoid prolonged exposure to extreme temperatures
While GLP-1 treatment decisions should always be guided by a healthcare professional, Medicard by iFinance helps Canadians plan for eligible healthcare expenses by offering predictable monthly payment options that spread costs over time
Current therapies are limited by adverse effects such as hypertension, hyperkalemia, and poor bioavailability, with no effective countermeasures targeting oxidative and endothelial-specific damage
71 TsiaoussisJAntoniouMNKoliarakisIMesnageRVardavasCIIzotovBNet al
Because that is ultimately what every DoD evaluator is asking: does this solve a real operational problem, and can this team deliver
